Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector
Highly pathogenic avian influenza virus (HPAIV) belongs to the <i>Orthomyxoviridae</i><i> </i>family and causes a systemic and highly lethal disease in poultry. Vaccination with recombinant Newcastle disease vector viruses (NDV) expressing the hemagglutinin (HA) of HPAIV H5N1...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-06-01
|
| Series: | Proceedings |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2504-3900/50/1/83 |
| _version_ | 1826994030647443456 |
|---|---|
| author | Magdalena Murr Olayinka Asala Axel Karger Christian Grund Thomas C. Mettenleiter Angela Römer-Oberdörfer |
| author_facet | Magdalena Murr Olayinka Asala Axel Karger Christian Grund Thomas C. Mettenleiter Angela Römer-Oberdörfer |
| author_sort | Magdalena Murr |
| collection | DOAJ |
| description | Highly pathogenic avian influenza virus (HPAIV) belongs to the <i>Orthomyxoviridae</i><i> </i>family and causes a systemic and highly lethal disease in poultry. Vaccination with recombinant Newcastle disease vector viruses (NDV) expressing the hemagglutinin (HA) of HPAIV H5N1 induces high antibody titers in chickens free of specific pathogens, conveying protection against a lethal infection with HPAIV H5N1. Protection of chickens possessing maternally derived NDV immunity was achieved after the replacement of the surface proteins of NDV, the fusion protein (F), and the hemagglutinin-neuraminidase protein (HN) against those of avian paramyxovirus serotype 8. However, maternal AIV antibodies (αAIV-MDA+) still interfere with vaccine virus replication, resulting in inefficient protection. For our study, recombinant rNDVsolH5_H5 was generated. The insertion of a transgene encoding a truncated soluble HA between the NDV phosphoprotein and matrix protein genes—in addition to the gene encoding a membrane-bound HA inserted between the NDV, F and HN of the lentogenic NDV Clone 30 —was expected to increase the total amount of HA expressed by the recombinant virus. Western blot and mass spectrometry analyses confirmed the increase in HA expression compared to the parental rNDVH5 expressing only the full-length HA. The protective efficacy of the newly generated recombinant NDV was tested in an animal experiment. αAIV-MDA+ chickens were vaccinated either 7, 14, or 21 days after hatching. A homologous challenge infection was carried out three weeks later. Although the youngest chickens showed the highest titer of αAIV-MDA, there were no AIV antibodies detectable 21 days after vaccination. However, 40% of vaccinated chickens were protected, while 85% and 100% protection was observed in the middle-aged and oldest chickens, which had low and no detectable levels of αAIV-MDA, and moderate and high AIV antibody levels after vaccination, respectively. Challenge infection of non-vaccinated chickens resulted in high mortality. |
| first_indexed | 2024-03-10T19:07:37Z |
| format | Article |
| id | doaj.art-fb298f05f1134795a9640b4159eb29e7 |
| institution | Directory Open Access Journal |
| issn | 2504-3900 |
| language | English |
| last_indexed | 2025-02-18T09:12:06Z |
| publishDate | 2020-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Proceedings |
| spelling | doaj.art-fb298f05f1134795a9640b4159eb29e72024-11-02T23:07:50ZengMDPI AGProceedings2504-39002020-06-015018310.3390/proceedings2020050083Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease VectorMagdalena Murr0Olayinka Asala1Axel Karger2Christian Grund3Thomas C. Mettenleiter4Angela Römer-Oberdörfer5Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyInstitute of Diagnostic Virology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyInstitute of Diagnostic Virology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyHighly pathogenic avian influenza virus (HPAIV) belongs to the <i>Orthomyxoviridae</i><i> </i>family and causes a systemic and highly lethal disease in poultry. Vaccination with recombinant Newcastle disease vector viruses (NDV) expressing the hemagglutinin (HA) of HPAIV H5N1 induces high antibody titers in chickens free of specific pathogens, conveying protection against a lethal infection with HPAIV H5N1. Protection of chickens possessing maternally derived NDV immunity was achieved after the replacement of the surface proteins of NDV, the fusion protein (F), and the hemagglutinin-neuraminidase protein (HN) against those of avian paramyxovirus serotype 8. However, maternal AIV antibodies (αAIV-MDA+) still interfere with vaccine virus replication, resulting in inefficient protection. For our study, recombinant rNDVsolH5_H5 was generated. The insertion of a transgene encoding a truncated soluble HA between the NDV phosphoprotein and matrix protein genes—in addition to the gene encoding a membrane-bound HA inserted between the NDV, F and HN of the lentogenic NDV Clone 30 —was expected to increase the total amount of HA expressed by the recombinant virus. Western blot and mass spectrometry analyses confirmed the increase in HA expression compared to the parental rNDVH5 expressing only the full-length HA. The protective efficacy of the newly generated recombinant NDV was tested in an animal experiment. αAIV-MDA+ chickens were vaccinated either 7, 14, or 21 days after hatching. A homologous challenge infection was carried out three weeks later. Although the youngest chickens showed the highest titer of αAIV-MDA, there were no AIV antibodies detectable 21 days after vaccination. However, 40% of vaccinated chickens were protected, while 85% and 100% protection was observed in the middle-aged and oldest chickens, which had low and no detectable levels of αAIV-MDA, and moderate and high AIV antibody levels after vaccination, respectively. Challenge infection of non-vaccinated chickens resulted in high mortality.https://www.mdpi.com/2504-3900/50/1/83avian influenza, H5N1, Newcastle disease, vector vaccine, DIVA, maternal immunity |
| spellingShingle | Magdalena Murr Olayinka Asala Axel Karger Christian Grund Thomas C. Mettenleiter Angela Römer-Oberdörfer Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector Proceedings avian influenza, H5N1, Newcastle disease, vector vaccine, DIVA, maternal immunity |
| title | Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector |
| title_full | Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector |
| title_fullStr | Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector |
| title_full_unstemmed | Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector |
| title_short | Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector |
| title_sort | protection of chickens with maternal avian influenza virus aiv immunity after vaccination with a recombinant aiv newcastle disease vector |
| topic | avian influenza, H5N1, Newcastle disease, vector vaccine, DIVA, maternal immunity |
| url | https://www.mdpi.com/2504-3900/50/1/83 |
| work_keys_str_mv | AT magdalenamurr protectionofchickenswithmaternalavianinfluenzavirusaivimmunityaftervaccinationwitharecombinantaivnewcastlediseasevector AT olayinkaasala protectionofchickenswithmaternalavianinfluenzavirusaivimmunityaftervaccinationwitharecombinantaivnewcastlediseasevector AT axelkarger protectionofchickenswithmaternalavianinfluenzavirusaivimmunityaftervaccinationwitharecombinantaivnewcastlediseasevector AT christiangrund protectionofchickenswithmaternalavianinfluenzavirusaivimmunityaftervaccinationwitharecombinantaivnewcastlediseasevector AT thomascmettenleiter protectionofchickenswithmaternalavianinfluenzavirusaivimmunityaftervaccinationwitharecombinantaivnewcastlediseasevector AT angelaromeroberdorfer protectionofchickenswithmaternalavianinfluenzavirusaivimmunityaftervaccinationwitharecombinantaivnewcastlediseasevector |